Medical device recalls Moderate risk

The Binding Site Group, Ltd. recalls FREELITE Human Kappa Free Kit for use on the Roche cobas c Systems, Kappa Freie Leichtkette (Human) kit for Roche cobas…

Recall date
May 20, 2021
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
Z-2030-2021
FDA classification
Class II
Brand / firm
The Binding Site Group, Ltd.
Sold / distributed
Worldwide distribution - US Nationwide distribution in the states of CA, GA, FL, MA, MO, MI, WA, NY, PA, MN, AL, MD, OK, NE, IN, ID, OH, TX, HI, DC and the countries of Canada, Australia, Austria, Belgium, Bulgaria, Canada, Cyprus, Czech Republic, Denmark, Estonia, France, Germany, Italy, Luxembour…

Why it was recalled

The high and low level "Quality Controls" demonstrate a positive bias of approximately 10% compared to assigned values.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

FREELITE Human Kappa Free Kit for use on the Roche cobas c Systems, Kappa Freie Leichtkette (Human) kit for Roche cobas c Systems, REF: LK016.CB, IVD CE, UDI: 05051700012096

Get recall alerts

Free email alert whenever The Binding Site Group, Ltd. has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: The Binding Site Group, Ltd.